Basics Ocugen, Inc. IPO Date: December 5, 2014 Sector: Healthcare Industry: Biotech Market Cap: $381.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 5.18% Avg Daily Range (30 D): $0.04 | 3.00% Avg Daily Range (90 D): $0.04 | 2.98% Institutional Daily Volume Avg Daily Volume: 13.47M Avg Daily Volume (30 D): 3.06M Avg Daily Volume (90 D): 3.92M Trade Size Avg Trade Size (Sh.): 355 Avg Trade Size (Sh.) (30 D): 398 Avg Trade Size (Sh.) (90 D): 505 Institutional Trades Total Inst.Trades: 1,711 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $.54M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $2.55M Avg Closing Trade (30 D): $.81M Avg Closing Trade (90 D): $.81M Avg Closing Volume: 862.53K     News Nov 19, 2025 @ 6:00 PM Gene Therapy for Ocular Rare Disease Market to Exh... Source: Delveinsight Sep 15, 2025 @ 11:04 PM Why Ocugen Stock Zoomed 12% Higher Today Source: Eric Volkman Aug 12, 2025 @ 7:45 PM Ocugen, Inc. Announces Closing of $20 Million Regi... Source: Tiffany Hamilton Aug 8, 2025 @ 9:03 PM Ocugen, Inc. Announces $20 Million Registered Dire... Source: Tiffany Hamilton Aug 5, 2025 @ 5:00 PM AAV for the Hereditary Retinal Diseases Clinical T... Source: Delveinsight Financials   TTM Q3 2025 Q2 2025 Basic EPS Diluted EPS Revenue $ 5.37M $ 1.75M $ 1.37M Gross Profit $ $ $ Net Income / Loss $ -64.02M $ -20.05M $ -14.74M Operating Income / Loss $ -59.76M $ -17.63M $ -13.8M Cost of Revenue $ $ $ Net Cash Flow $ -6.12M $ 5.55M $ -10.79M PE Ratio     Splits Sep 30, 2019:   1:60